Healionics aims to provide safer, more reliable means of bloodstream access for dialysis in patients with kidney failure.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, US
  • Currency USD
  • Founded March 2007
  • Employees 7
  • Incorporation Type C-corp
  • Website healionics.com

Company Summary

Patients without functional kidneys need frequent blood filtration via dialysis to survive, but current methods to repeatedly access the bloodstream are risky, unreliable, and costly. A synthetic blood vessel (“vascular graft”) is often implanted to create an access site with sufficient flow for dialysis, but existing grafts fail due to occlusion &/or infection. Healionics’ STARgraft shows superior resistance to both problems in human studies.


  • 30 years experience in the medical device industry as an entrepreneur, venture capitalist, and CEO. Cofounded several device companies, three of which (Novacept, Cohesion Technologies, Pulmonx) have reached exits worth a combined >$2B. Led the regional office for $400M venture capital firm vSpring (now Signal Peak). CEO of two early-stage device companies. Stanford MBA, M.I.T. MS, U.S. Naval Academy BS.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free